BCIC vs BIO · P/E 32, $92.3M cap vs rev $2.58B
BCP Investment Corp. (BCIC) versus BIO (BIO) — a side-by-side from cached financials, not a winner call.
BCP Investment Corp. (BCIC) is a asset management company listed on NASDAQ.
BIO (BIO) common stock.
BCIC does not have a complete income-statement cache yet.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
BCIC currently screens at market cap $92.3M and trailing P/E 32.4. BIO currently screens at market cap $0.
Not investment advice. Open the BCIC and BIO stock pages for the full models.
Not investment advice.